$0.879
-0.057 (-6.51%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
AKBA Prediction & Forecast by Similar Chart Analysis
Alphio's AKBA stock price prediction model matches the current Akebia Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.87 (-1.22%). The 1-week path is $0.84 (-4.44%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Akebia Therapeutics Inc Stock?
Akebia Therapeutics Inc is not a good buy right now due to declining revenues and negative earnings reports. The current price is $0.8786, with a 21.6% year-over-year revenue decline reported in Q2 2026, despite a slight earnings surprise. Additionally, the RSI is at 38.919, indicating oversold conditions, but the overall trend remains negative with a 71.75% decline over the past year, suggesting further downside risk.
AKBA stock price ended at $0.88 on Friday, after losing -6.51%
Akebia Therapeutics Inc (AKBA) last closed at $0.8786, losing -6.51%. These facts feed the 1-day and 1-week AKBA price prediction above.
Analyst Consensus
Akebia Therapeutics Inc (AKBA): 6 buy, 1 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Akebia Therapeutics Inc (AKBA) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches AKBA, ranked by similarity.
Seasonality analysis for AKBA
Historically the probability of a positive August return for AKBA is 57.14%. September offers the highest probability of a positive month at 100.00%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for AKBA
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $2.65 | $3.42 | $3.85 | +289.22% |
| Sep 2026 | $2.69 | $3.24 | $3.82 | +268.94% |
| Oct 2026 | $4.05 | $4.09 | $4.46 | +366.03% |
| Nov 2026 | $3.15 | $3.98 | $4.61 | +353.06% |
| Dec 2026 | $2.84 | $3.65 | $4.36 | +315.49% |
In 2026, Akebia Therapeutics Inc (AKBA) is projected to range from $2.65 to $4.61.
Akebia Therapeutics Inc 2026 monthly forecast
In Aug 2026, Akebia Therapeutics Inc is projected to average $3.42, with a low of $2.65 and high of $3.85.
In Sep 2026, Akebia Therapeutics Inc is projected to average $3.24, with a low of $2.69 and high of $3.82.
In Oct 2026, Akebia Therapeutics Inc is projected to average $4.09, with a low of $4.05 and high of $4.46.
In Nov 2026, Akebia Therapeutics Inc is projected to average $3.98, with a low of $3.15 and high of $4.61.
In Dec 2026, Akebia Therapeutics Inc is projected to average $3.65, with a low of $2.84 and high of $4.36.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.